Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EHSG-KF versus split-thickness skin graft for large full-thickness skin defects
NL-OMON59817Phase 2Completed
- Sponsor
- CUTISS
- Start
- May 2019
- Countries
- 1
01
Overview
Phase 2, open-label trial (2 arms), sponsored by CUTISS. Primary endpoint: General scar quality. Started May 2019; status: completed.
Beyond the preview
Go deeper on NL-OMON59817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59817.